Heparin Nomogram: Weight-based induction and titration. Accuracy is vital to reach therapeutic range (aPTT 1.5–2.5x mean normal) within 24 hours.
Phase 1: Induction
Phase 2: Titration
Guidelines & Evidence
Clinical Details
Section 1
When to Use
When to Use
Initiating Unfractionated Heparin (UFH) for acute VTE (DVT/PE) or ACS.
Calculating initial bolus and infusion rates based on patient weight.
Monitoring and adjusting dose based on therapeutic aPTT or Anti-Xa levels.
Exclusions
Do not use this weight-based protocol for patients with heparin-induced thrombocytopenia (HIT). Use argatroban or danaparoid instead.
Section 2
Formula & Logic
Initial Dosing (VTE Protocol)
Component
Weight-Based Dose
Loading Bolus
80 units/kg (Max 5,000 – 10,000)
Initial Infusion
18 units/kg/hr
Lab Monitoring
Check aPTT or Anti-Xa levels 6 hours after any change in dose and 6 hours after the initial infusion start.
Section 3
Titration Grid
aPTT-Based Adjustment
aPTT (sec)
Bolus
Hold
Rate Change
< 35
80 u/kg
0 min
+4 u/kg/hr
35 - 45
40 u/kg
0 min
+2 u/kg/hr
46 - 70
None
0 min
No change
71 - 90
None
0 min
-2 u/kg/hr
> 90
None
60 min
-3 u/kg/hr
Section 4
Pearls/Pitfalls
Heparin Resistance
Patients who fail to reach therapeutic aPTT despite very high heparin doses (>35,000 units/day) may have "Heparin Resistance," often due to antithrombin III deficiency or high levels of factor VIII. Switching to Anti-Xa monitoring is more reliable in these cases.
Section 5
Evidence Appraisal
Primary Score
The weight-based heparin nomogram compared with standard care: a randomized controlled trial.
Raschke RA et al. • Annals of Internal Medicine. 1993;119(11):1100-3.
Before the Raschke nomogram, heparin was often dosed using empirical "fixed-dose" schemes, which resulted in significant under-anticoagulation in large patients and bleed risk in small patients.